Shandong Weigao boosts treasury holdings with share repurchase

Shandong Weigao Group Medical Polymer Company Limited reported a share repurchase on September 4, 2025. The company bought back 1,123,600 H-shares on the exchange at prices ranging from HK$5.6 to HK$5.79 per share, totaling an aggregate cost of HK$6,382,024. These repurchased shares will be held as treasury shares, increasing the total treasury share count from 12,838,000 to 13,961,600.

The repurchase represents a 0.0249% change relative to the existing number of issued shares (excluding treasury shares) before the event. Following this transaction, the number of issued shares (excluding treasury shares) decreased to 4,508,370,724. The company's mandate allows for the repurchase of up to 451,560,392 shares, with 7,313,200 shares repurchased to date under this authority.

A moratorium period for issuing new shares or selling treasury shares is in effect until October 4, 2025. The repurchase was conducted in accordance with Main Board Rules and the company's explanatory statement filed on April 30, 2025.